News | Brachytherapy Systems | September 13, 2019

Isoray to Spotlight Cesium-131 Advances at ASTRO Annual Meeting

Company will highlight ability of Cesium-131 brachytherapy to treat traditionally difficult cancers

Isoray to Spotlight Cesium-131 Advances at ASTRO Annual Meeting

September 13, 2019 — Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131 brachytherapy at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago.

During the meeting, attendees will have the opportunity to learn about the mounting body of clinical evidence illustrating the expanding use of Cesium-131, now known as Cesium Blu, and its effectiveness in treating recurrent brain cancers including meningiomas and brain metastases.

Attendees will also get a first-hand look at the Blu Build real-time Cesium-131 internal radiation therapy delivery system. Blu Build is believed to be the first new delivery system in years designed specifically for prostate internal radiation therapy, according to the company. The delivery system enables doctors to deliver a high radiation dose to the targeted prostate cancer and limits the impact on the surrounding areas compared to other treatment options. 

Isoray representatives will be at the company’s booth to discuss recent developments with attendees regarding clinical applications where Cesium-131 has been found to be a potent, valuable option for clinicians and their patients.

For more information: www.isoray.com

Related Content

Image courtesy of Elekta 

News | Radiation Therapy | December 11, 2019
December 11, 2019 — A new clinical guideline from the American Soci...
RaySearch Laboratories AB (publ) has experienced strong growth in recent years, creating the need for larger and more efficient premises
News | Radiation Therapy | December 09, 2019
December 9, 2019 — Karin Gedda, architect and i
radiation therapy non-Hodgkin's lymphoma
News | Radiation Oncology | December 09, 2019
December 9, 2019 — Most people diagnosed with the most common type of non-Hodgkin's lymphoma can safely skip radiatio
After receiving acupuncture treatment three days a week during the course of radiation treatment, head and neck cancer patients experienced less dry mouth, according to study results from researchers at The University of Texas MD Anderson Cancer Center

Image by Rudolf Langer from Pixabay 

News | Clinical Trials | December 06, 2019
December 6, 2019 — After receiving acupuncture treatment three days a week during the course of...
Timothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Research Chair in Breast Cancer Research. Photo courtesy McMaster University

Timothy Whelan is a professor of oncology at McMaster University and a radiation oncologist at the Juravinski Cancer Centre of Hamilton Health Sciences. He holds a Canada Research Chair in Breast Cancer Research. Photo courtesy McMaster University. Photo courtesy of McMaster University

News | Breast Imaging | December 06, 2019
December 6, 2019 — A shorter course of higher-dose radiation treatment to part of the breast is showing promise in wo
Sponsored Content | Videos | Quality Assurance (QA) | December 06, 2019
Modus QA is proud to offer a superior phantom for quantifying geometric distortion in modern MRgRT applications. Watc